Skip to content
MarketScale
‹ Back to IndustriesHealthcare

How Hospitals Can Adapt to Supply Chain Disruptions

COVID-19 has brought increasingly disruptive ripple effects across each of the world’s industries, but healthcare has been hit particularly hard. In addition to managing the increased stressors associated directly with the pandemic, healthcare providers the world over are dealing with the fallout of severe disruptions throughout their supply chains. In uncertain periods such as this,…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
How Hospitals Can Adapt to Supply Chain Disruptions

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

COVID-19 has brought increasingly disruptive ripple effects across each of the world’s industries, but healthcare has been hit particularly hard.

In addition to managing the increased stressors associated directly with the pandemic, healthcare providers the world over are dealing with the fallout of severe disruptions throughout their supply chains.

In uncertain periods such as this, TPC stands ready to assist its Member hospitals in finding agile solutions to these disruptions that allow operations to remain as close to normal as possible as we collectively work through the challenges set in front of us.

As COVID-19 Proves, Healthcare Providers Must Be Ready to Pivot at a Moment’s Notice

Though COVID-19 is far from the first disruptive force healthcare supply chains have been asked to navigate, it has presented some unique challenges.

It’s more important than ever to evaluate best practices in adapting and responding to these disruptions.

First, it’s critical to thoroughly review not only your own supply chain, but the state of key drugs, other products, and their manufacturers. The FDA has been diligent in working with manufacturers of both drugs and medical equipment to get an idea of exactly how disruptive this pandemic might be, and it’s important that you leverage that information as often as you can to formulate a plan of attack that addresses potential impacts on your own supply chain.

Proactive risk management plans, data sharing and collaboration can ensure you’re firmly on the front line in fighting these disruptions and continuing to provide the key services and quality care for your patients.

Several best practices have also been recommended during this pandemic, including:

  • Providing education regarding COVID-19 to staff.
  • Rationing masks and personal protective equipment and curtailing areas where these products are available for use.
  • Managing N-95 mask usage and creating a proactive plan regarding nurses who will use the masks, careful attention to reuse guidelines, and more.

TPC is Proud to Help Guide You Through Uncertainty

As uncertainty mounts in the face of these supply chain disruptions, TPC is, as always, committed to acting as your guide toward proactive, beneficial action and working to source new suppliers and evaluate innovative solutions to assist our Members in their time of need.

With TPC’s ongoing commitment to communication and support, you can be confident in your ability to navigate these temporary disruptions and continue providing the best possible care to your patients.

Disruptions are going to occur, and COVID-19 is far from the last – however, by being flexible in addressing these challenges, we can work together to find solutions, providing valuable support within the TPC Member family.

To learn more or reach out with any specific questions, visit tpc1.com.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

The Cost of Waiting: Why Healthcare Can't Afford Slow Decisions with Mark Van Sumeren

The Cost of Waiting: Why Healthcare Can't Afford Slow Decisions with Mark Van Sumeren

The healthcare industry faces significant consequences when delayed decision-making occurs. Prompt and efficient action is crucial to prevent adverse impacts on patient care and operational efficiency. Addressing this issue requires a commitment to more agile and informed decision processes.

  • 01Delayed decision-making in healthcare can lead to negative impacts on patient care and operational efficiency.
  • 02Healthcare organizations are encouraged to adopt agile decision-making processes to improve effectiveness.
  • 03Implementing informed and prompt decision-making strategies can mitigate the risks of inefficiencies and poor patient outcomes.

Aug 17, 2026

Medicare's ACCESS pilot is live, but patients can't find which providers offer it

Medicare's ACCESS pilot is live, but patients can't find which providers offer it

The Centers for Medicare & Medicaid Services (CMS) launched its tech-enabled chronic care pilot program, known as the ACCESS pilot. Despite its initiation, a significant issue persists as patients struggle to find which healthcare providers are participating in the program. Meanwhile, the FDA has authorized 115 AI-based medical devices in 2021.

  • 01CMS has initiated the ACCESS pilot program to enhance chronic care management using technology.
  • 02Patients are facing challenges in identifying healthcare providers involved in the ACCESS pilot.
  • 03In 2021, the FDA authorized 115 AI-based medical devices.

Aug 17, 2026

Sobi CEO Guido Oelkers named BioNTech's next chief executive, targeting multiple approved products by 2030

Sobi CEO Guido Oelkers named BioNTech's next chief executive, targeting multiple approved products by 2030

BioNTech has appointed Guido Oelkers, the current CEO of Sobi, as its next chief executive. Oelkers is tasked with advancing BioNTech's oncology pipeline to achieve multiple approved products by 2030.

  • 01BioNTech has selected Guido Oelkers as its new CEO, effective soon.
  • 02Guido Oelkers aims to turn BioNTech's deep oncology pipeline into several approved products by 2030.

Aug 17, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512